Note
Prompt for adversarial review of the PandemicSociety101 / SGIR paper.
iv_LLoL_v1_2026m04d18wwv-sgir-evolvix-study-dv_llol_oov1_2026m04d17.rstPrompt: Adversarial Review of the SGIR / PandemicSociety101 Paper#
Context#
You are reviewing a scientific paper draft:
source/good-news-pack/vv/mmv3/flyingscroll/transwarpkey/sta2-wwv/wwv-sgir-evolvix-study-dv_llol_oov1_2026m04d17.rst
This paper presents the SGIR model (an extension of SIR that tracks the Gap of Germs), the PandemicSociety101 stochastic simulation, and results showing that coordinated NPIs can produce a 60-fold reduction in pandemic infections. It also introduces the HalfMax early-warning method, the linear fooling concept, work-logic cascades, Virodefense Olympics, and the ResearchCity vision.
The paper is intended for arXiv upload as a preprint and is designed to establish scientific credibility for the author (Laurence Loewe) as part of a broader body of work. Key target readers include: Pope Leo XIV (mathematical background), Francis Collins (Christian scientist, former NIH director), and Anthony Fauci (infectious disease expert). The paper must survive both scientific peer review and hostile media scrutiny.
Read the full paper before beginning the review.
Also read the figures. The figure files are at:
source/_file/pdf/gnp/mmv3/flyingscroll/transwarpkey/sta2-wwv/pandemicsociety101/b11/
(files named fig01 through fig13, plus the Evolvix code file).
Instructions#
Run 7 adversarial review panels. For each panel:
State the reviewer’s identity, expertise, and what they are looking for.
Give 3–5 specific strengths (what would make this reviewer take the paper seriously).
Give 3–5 specific weaknesses or concerns (what would make this reviewer dismiss, attack, or ignore the paper).
Give a verdict: ENGAGE (would respond/cite), IGNORE (not worth responding to), or ATTACK (would actively critique).
Give 1–3 specific revision recommendations.
Use HELD / BREACH (not PASS/FAIL) for any testing assessments.
Panel 1: Epidemiologist / Mathematical Modeler#
Identity: Senior epidemiologist at a major university, experienced with SIR-family models, has published on COVID-19 modeling. Reviews for journals like Epidemics, Journal of Theoretical Biology, or PLOS Computational Biology.
What they check:
Is the SGIR extension genuinely novel or just a restatement of known transmission chain models?
Are the parameter choices justified and calibrated to real data?
Is the 60-fold reduction result robust or an artifact of specific parameter choices?
Is the ASHA framework a genuine contribution or unnecessary complexity?
Is the HalfMax method useful or trivially obvious?
Are the stochastic simulations properly implemented (SSA vs ODE comparison)?
How does this compare to established COVID-19 models (e.g., Imperial College, IHME)?
Panel 2: Hostile Investigative Journalist#
Identity: Science journalist who has covered COVID-19 controversies. Looking for a story, whether positive or negative. Will quote-mine the most dramatic sentences.
What they check:
What is the headline? (Both best-case and worst-case framing.)
Does the author make claims that exceed the evidence?
Are there statements that sound grandiose or delusional?
Is the “ResearchCity” / “Virodefense Olympics” vision credible or does it sound like a fantasy?
Does the personal anecdote (16 infections, failure to recognize) help or hurt credibility?
Would this paper survive fact-checking?
Is the AI co-authorship a story in itself?
Panel 3: Catholic Scientist (Vatican Science Advisor)#
Identity: Physicist or mathematician on the Pontifical Academy of Sciences, advising Pope Leo XIV. Familiar with mathematical modeling, takes both science and faith seriously.
What they check:
Is the science rigorous enough for the Vatican to engage without embarrassment?
Does the paper make any theological claims (explicit or implicit)?
Is the ResearchCity vision compatible with Catholic social teaching (common good, subsidiarity, solidarity)?
Would recommending this paper to the Pope create a reputational risk for the advisor?
Is the $8/person/year funding model credible?
Does the author appear to be a serious scientist or a crank?
Panel 4: NIH-Style Reviewer (Collins / Fauci Perspective)#
Identity: Senior scientist at NIH or a major US research university, has served on NIH study sections. Evaluates whether this is credible enough to cite, build on, or collaborate with.
What they check:
Does this meet the minimal bar for a citable preprint?
Is the model well enough specified that someone could reproduce the results?
Are the claims proportional to the evidence?
Is the Evolvix language a barrier to reproducibility (proprietary tool, no public compiler)?
How does this compare to the author’s prior publication record?
Would engaging with this author carry reputational risk?
Is the pandemic preparedness vision actionable or aspirational?
Panel 5: Computational Biology / Evolvix Reviewer#
Identity: Computational biologist experienced with stochastic simulation, process algebras, and domain-specific languages for biology. Has used tools like BioNetGen, COPASI, or Bio-PEPA.
What they check:
Is the Evolvix code readable and reproducible without the (unpublished) compiler?
Is the ASHA framework a genuine modeling advance or unnecessary abstraction?
Are the model equations properly specified (or only implied by the code)?
Is the Sorting Direct Method properly attributed and implemented?
Does the paper adequately compare Evolvix to existing modeling frameworks?
Is the “pandemic-grade language” claim in Section 4.5 justified?
Panel 6: COVID-Politics Reviewer#
Identity: Social scientist who studies COVID-19 misinformation, public health communication, and the politics of pandemic response.
What they check:
Does the “linear fooling” concept risk being misused to argue that “testing was useless” or “the numbers were all fake”?
Does the paper’s framing support or undermine public trust in institutions (CDC, WHO, public health)?
Could the “even experts get fooled” anecdote be weaponized by anti-science movements?
Does the Virodefense Olympics idea address or ignore the trust deficit that plagued COVID-19 response?
Is the $8/person crowdfunding model a genuine alternative to institutional funding or does it sound like a GoFundMe campaign?
Panel 7: Global South Reviewer#
Identity: Epidemiologist or public health researcher based in Sub-Saharan Africa, South Asia, or Latin America. Has worked on pandemic response in resource-limited settings.
What they check:
Is the paper entirely US-centric (330M population, CDC data)?
Does the SGIR model apply to settings with different population densities, healthcare systems, and NPI adoption patterns?
Is the $8/person/year realistic in countries where annual health expenditure per capita is under $50?
Does the work-logic cascade framework account for informal economies, community-based health systems, and non-Western organizational structures?
Does the paper acknowledge that “coordinated NPI adoption” looks very different in a dense informal settlement than in a US suburb?
Output Format#
For each panel, use this structure:
Panel N: [Reviewer Type]
========================
**Strengths:**
1. ...
2. ...
3. ...
**Concerns:**
1. ...
2. ...
3. ...
**Verdict:** ENGAGE / IGNORE / ATTACK
**Revision recommendations:**
1. ...
2. ...
After all 7 panels, provide:
Cross-panel summary: Which concerns appear across multiple panels? These are the highest-priority fixes.
EDEN classification of the paper’s overall position.
Recommended revision priority list (ordered by impact on target reader engagement).
LLog#
Append the full review to the b18 writing llog at:
source/matheology/hell/ll/study/b/18/study_ll_2026m04d16_b18-call-to-action-writing-llog.rst
Use a new section number (continuing from the last section in that llog). Include this verbatim prompt and all panel results.
If the llog is getting too long, create a new companion llog at:
source/matheology/hell/ll/study/b/18/study_ll_2026m04d18_sgir-paper-review-llog.rst
and cross-reference it from the main llog.